Your browser doesn't support javascript.
loading
Expanding health technology assessment towards broader value: Ireland as a case study.
Kinchin, Irina; Walshe, Valerie; Normand, Charles; Coast, Joanna; Elliott, Rachel; Kroll, Thilo; Kinghorn, Philip; Thompson, Alexander; Viney, Rosalie; Currow, David; O'Mahony, James F.
  • Kinchin I; Centre for Health Policy and Management, Trinity College Dublin, The University of Dublin, Dublin, Ireland.
  • Walshe V; Health Service Executive, Dublin, Ireland.
  • Normand C; Centre for Health Policy and Management, Trinity College Dublin, The University of Dublin, Dublin, Ireland.
  • Coast J; Bristol Population Health Science Institute, University of Bristol, Bristol, UK.
  • Elliott R; Manchester Centre for Health Economics, The University of Manchester, Manchester, UK.
  • Kroll T; School of Nursing, Midwifery and Health Systems, University College Dublin, Dublin, Ireland.
  • Kinghorn P; Health Economics Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Thompson A; Manchester Centre for Health Economics, The University of Manchester, Manchester, UK.
  • Viney R; Centre for Health Economics Research and Evaluation (CHERE), University of Technology Sydney, Ultimo, NSW, Australia.
  • Currow D; Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW, Australia.
  • O'Mahony JF; Centre for Health Policy and Management, Trinity College Dublin, The University of Dublin, Dublin, Ireland.
Int J Technol Assess Health Care ; 39(1): e26, 2023 May 02.
Article en En | MEDLINE | ID: mdl-37129030
ABSTRACT
Healthcare innovations often represent important improvements in population welfare, but at what cost, and to whom? Health technology assessment (HTA) is a multidisciplinary process to inform resource allocation. HTA is conventionally anchored on health maximization as the only relevant output of health services. If we accept the proposition that health technologies can generate value outside the healthcare system, resource allocation decisions could be suboptimal from a societal perspective. Incorporating "broader value" in HTA as derived from social values and patient experience could provide a richer evaluative space for informing resource allocation decisions. This article considers how HTA is practiced and what its current context implies for adopting "broader value" to evaluating health technologies. Methodological challenges are highlighted, as is a future research agenda. Ireland serves as an example of a healthcare system that both has an explicit role for HTA and is evolving under a current program of reform to offer universal, single-tier access to public services. There are various ways in which HTA processes could move beyond health, including considering the processes of care delivery and/or expanding the evaluative space to some broader concept of well-being. Methods to facilitate the latter exist, but their adaptation to HTA is still emerging. We recommend a multi-stakeholder working group to develop and advance an international agenda for HTA that captures welfare/benefit beyond health.
Asunto(s)
Palabras clave

Texto completo: 1 Ejes tematicos: Inovacao_tecnologica Banco de datos: MEDLINE Asunto principal: Evaluación de la Tecnología Biomédica / Atención a la Salud Tipo de estudio: Health_technology_assessment / Prognostic_studies Límite: Humans País como asunto: Europa Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Ejes tematicos: Inovacao_tecnologica Banco de datos: MEDLINE Asunto principal: Evaluación de la Tecnología Biomédica / Atención a la Salud Tipo de estudio: Health_technology_assessment / Prognostic_studies Límite: Humans País como asunto: Europa Idioma: En Año: 2023 Tipo del documento: Article